Follow us for updates
© 2022
Read the Story →

FDA Clears Moderna Vaccine for Emergency Use on 12 to 17 Year-Olds

As more children get infected with COVID-19.
by Pia Regalado
Sep 3, 2021
Photo/s: Shutterstock

The Food and Drug Administration said Friday it cleared Moderna's COVID-19 vaccine for emergency use on minors aged 12 to 17 as more young people get infected with COVID-19.

Moderna applied for an amendment to its emergency use authorization or (EUA) two weeks ago to include its use in adolescents, FDA Director General Eric Domingo said.

"With the Delta variant affecting a lot of children, nakita po ng ating mga expert that the benefit of using the vaccine outweighs the risk," Domingo said.

The Philippines so far allows COVID-19 vaccination for those aged 18 and above. The DOH urged adults with kids at home to get vaccinated instead to lower the chances of children getting infected.


12 to 15 Year-Olds with Comorbidities Can Get Pfizer COVID Vaccine, Says DOH

Children's Noses are 'Pre-Activated' to Fight Coronavirus, Study Shows

Domingo said the Moderna jabs in the Philippines do not belong to the same contaminated lot that was also sent to Japan.

Continue reading below ↓


What We Know About Japan's Contaminated Moderna COVID Jabs

Japan Probes Two Deaths After Jabs from Tainted Moderna Batch

Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
Some relief from rising prices.
With the reopening of several local destinations, this app has never been more timely.
Landmark Roe vs Wade ruling of 1973 is overturned.
Its rise mirrors the rise of technology for the masses.
It cites global uncertainties for its move.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.